NCT04301284 - Study of CAD-1883 for Spinocerebellar Ataxia | Biotech Hunter

Timeline

Start Date

June 30, 2021

Primary Completion Date

November 30, 2022

Study Completion Date

December 31, 2022

Conditions

Spinocerebellar AtaxiasSpinocerebellar Ataxia Type 1Spinocerebellar Ataxia Type 2Spinocerebellar Ataxia Type 3Spinocerebellar Ataxia Type 6Spinocerebellar Ataxia Type 7Spinocerebellar Ataxia Type 8Spinocerebellar Ataxia Type 10Spinocerebellar Ataxia Type 17ARCA1 - Autosomal Recessive Cerebellar Ataxia Type 1

Interventions

DRUG

CAD-1883

150 mg filled capsules

DRUG

Placebos

capsules

Trial Locations (6)

32608

University of Florida, Gainesville

33612

University of South Florida: Ataxia Research Center, Tampa

77030

Houston Methodist Research Institute, Houston

80045

University of Colorado, Aurora

90095

UCLA Medical Center, Los Angeles

90806

Collaborative Neuroscience Network, Long Beach